LEGATO-HD
Alternative name: NCT02215616,
1 Documentos
Cerrar
1 Referencias ( articles) loading Revertir Estudificar

Estudio primario

No clasificado

Registro de estudios ClinicalTrials.gov
Año 2014
Cargando información sobre las referencias
The primary objective of this study is to assess the efficacy of laquinimod as treatment in participants with HD after 52 weeks using the Unified Huntington\'s Disease Rating Scale Total Motor Score (UHDRS-TMS or TMS).